Endoscopic Evaluation After Esophagectomy
- Conditions
- Esophageal NeoplasmsAnastomotic LeakIschemiaConstriction
- Interventions
- Procedure: Patients after esophagectomy
- Registration Number
- NCT02703142
- Lead Sponsor
- Nagasaki University
- Brief Summary
Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.
- Detailed Description
Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. However the evaluation and prevention before developing gastric conduit ischemia have been established. The investigators have built a hypothesis that the evaluation for gastric mucosal ischemia in early phase after esophagectomy predict the complication of gastric conduit. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Malignant or end-stage benign esophageal disease.
- Esophagectomy with reconstruction by a gastric pull-up.
- Severe heart failure and pulmonary dysfunction
- Severe renal and liver dysfunction
- Allergenic history
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients after esophagectomy Patients after esophagectomy Endoscopic examinations are performed at 1, 8, and 15 postoperative days. Endoscopic examination is added when abnormal findings are demonstrated.
- Primary Outcome Measures
Name Time Method Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo Classification From 1 to 29 days after esophagectomy Number of participants with the classification of gastric conduit ischemia by endoscopic findings From 1 to 15 days after esophagectomy Number of participants with the major complications of gastric conduit (strictures, leakage, necrosis) From 1 to 29 days after esophagectomy
- Secondary Outcome Measures
Name Time Method Biological examination of the mucosal biopsy of gastric conduit as assessed by the scoring system for immunohistochemical staining From 1 to 29 days after esophagectomy The scoring system refer to the article entitled a scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group (J Clin Pathol. 1997 Oct; 50(10): 801-804.)
Biological examination of the mucosal biopsy of gastric conduit as assessed by the ischemia related RNA copy number From 1 to 29 days after esophagectomy Biological examination of gastric conduit as assessed by the Mitochondrial DNA copy number From 1 to 29 days after esophagectomy
Trial Locations
- Locations (1)
Nagasaki University Hospital
🇯🇵Nagasaki, Japan